Neuralink is set to begin a groundbreaking clinical trial in October 2025, offering hope to individuals with severe speech impairments. The FDA-cleare ...
35mon MSN
White House Justifies USD 100,000 H-1B Visa Fee Hike, Cites Job Losses Among American Workers
The White House cited several examples of companies hiring large numbers of H-1B workers while laying off thousands of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback